Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cronos GroupTilrayAurora CannabisSundial GrowersUSANA Health Sciences
SymbolNASDAQ:CRONNASDAQ:TLRYNYSE:ACBNASDAQ:SNDLNYSE:USNA
Price Information
Current Price$8.88$19.76$8.91$1.00$99.89
52 Week RangeHoldHoldHoldSellBuy
MarketRank™
Overall Score0.81.01.31.02.0
Analysis Score0.92.02.80.73.5
Community Score2.32.32.33.02.2
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.01.7
Earnings & Valuation Score0.60.61.31.32.5
Analyst Ratings
Consensus RecommendationHoldHoldHoldSellBuy
Consensus Price Target$8.50$18.31$10.93$0.73$126.00
% Upside from Price Target-4.28% downside-7.35% downside22.63% upside-26.67% downside26.14% upside
Trade Information
Market Cap$3.20 billion$3.39 billion$1.76 billion$1.66 billion$2.06 billion
Beta2.073.123.447.010.98
Average Volume6,129,46439,321,60922,186,193499,869,844118,913
Sales & Book Value
Annual Revenue$25.64 million$166.98 million$207.89 million$75.86 million$1.06 billion
Price / Sales124.7720.338.4921.891.94
Cashflow$0.60 per shareN/AN/AN/A$7.23 per share
Price / Cash14.76N/AN/AN/A13.82
Book Value$5.01 per share$2.78 per share$13.73 per share$1.56 per share$16.25 per share
Price / Book1.777.110.650.646.15
Profitability
Net Income$1.17 billion$-321,170,000.00$-2,468,190,000.00$-204,570,000.00$100.53 million
EPS$0.67($1.69)($2.86)($3.17)$4.41
Trailing P/E Ratio37.00N/AN/AN/A18.50
Forward P/E RatioN/AN/AN/AN/A18.33
P/E GrowthN/AN/AN/AN/A0.96
Net Margins266.31%-242.60%-1,238.94%-415.89%10.57%
Return on Equity (ROE)-1.61%-92.70%-16.32%-187.67%32.91%
Return on Assets (ROA)-1.41%-20.70%-13.12%-72.67%22.26%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A2.75%0.17%0.66%N/A
Current Ratio9.75%2.28%1.88%0.85%2.40%
Quick Ratio9.36%1.61%1.07%0.50%1.91%
Ownership Information
Institutional Ownership Percentage11.75%12.62%11.86%3.32%54.12%
Insider Ownership Percentage7.93%16.75%N/AN/A45.40%
Miscellaneous
Employees6311,6462,7318681,943
Shares Outstanding360.26 million171.76 million197.98 million1.66 billion20.62 million
Next Earnings Date5/14/2021 (Estimated)5/10/2021 (Estimated)5/13/2021 (Estimated)5/21/2021 (Estimated)4/27/2021 (Confirmed)
OptionableOptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
Do USANA Health Sciencess (NYSE:USNA) Earnings Warrant Your Attention?Do USANA Health Sciences's (NYSE:USNA) Earnings Warrant Your Attention?
finance.yahoo.com - April 9 at 5:31 PM
USANA Dives Into Partnership With USA SwimmingUSANA Dives Into Partnership With USA Swimming
finance.yahoo.com - April 7 at 12:32 PM
Usana Health Sciences Stock Appears To Be Fairly ValuedUsana Health Sciences Stock Appears To Be Fairly Valued
finance.yahoo.com - March 28 at 5:53 PM
USANA Health Sciences (NYSE:USNA) versus Aphria (NASDAQ:APHA) Head-To-Head ReviewUSANA Health Sciences (NYSE:USNA) versus Aphria (NASDAQ:APHA) Head-To-Head Review
americanbankingnews.com - March 24 at 10:58 AM
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?USNA vs. ZTS: Which Stock Should Value Investors Buy Now?
finance.yahoo.com - March 17 at 1:38 PM
Applying New 3Rs Gets Workers through Pandemic, Global Author/CEO SaysApplying New 3Rs Gets Workers through Pandemic, Global Author/CEO Says
finance.yahoo.com - March 17 at 1:38 PM
At US$96.90, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?At US$96.90, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
finance.yahoo.com - March 10 at 12:59 PM
USANA Health (USNA) Soars to 52-Week High, Time to Cash Out?USANA Health (USNA) Soars to 52-Week High, Time to Cash Out?
finance.yahoo.com - March 5 at 2:14 PM
USNA or ZTS: Which Is the Better Value Stock Right Now?USNA or ZTS: Which Is the Better Value Stock Right Now?
finance.yahoo.com - March 1 at 2:35 PM
USANA executive director recognized as a top young leader in UtahUSANA executive director recognized as a top young leader in Utah
finance.yahoo.com - February 25 at 2:22 PM
USANA Announces Formation of Board Sustainability CommitteeUSANA Announces Formation of Board Sustainability Committee
finance.yahoo.com - February 16 at 7:19 PM
Moving Average Crossover Alert: USANA Health Sciences (USNA)Moving Average Crossover Alert: USANA Health Sciences (USNA)
nasdaq.com - February 16 at 9:15 AM
USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q4 2020 Results - Earnings Call TranscriptUSANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 12 at 9:29 AM
Does This Valuation Of USANA Health Sciences, Inc. (NYSE:USNA) Imply Investors Are Overpaying?Does This Valuation Of USANA Health Sciences, Inc. (NYSE:USNA) Imply Investors Are Overpaying?
finance.yahoo.com - February 11 at 1:43 PM
USNA vs. CTLT: Which Stock Is the Better Value Option?USNA vs. CTLT: Which Stock Is the Better Value Option?
finance.yahoo.com - February 11 at 1:43 PM
Why AzurRx BioPharma, Usana Health Are Moving TodayWhy AzurRx BioPharma, Usana Health Are Moving Today
msn.com - February 10 at 2:25 PM
Price Over Earnings Overview: Usana Health SciencesPrice Over Earnings Overview: Usana Health Sciences
finance.yahoo.com - February 10 at 2:24 PM
USANA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call PresentationUSANA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - February 10 at 5:11 AM
USANA Health Sciences Announces Gain In Q4 EarningsUSANA Health Sciences Announces Gain In Q4 Earnings
nasdaq.com - February 9 at 7:15 PM
USANA Health Sciences Finishes Strong 2020 with 14.5% Fourth Quarter Net Sales Growth and 32.6% Diluted EPS GrowthUSANA Health Sciences Finishes Strong 2020 with 14.5% Fourth Quarter Net Sales Growth and 32.6% Diluted EPS Growth
finance.yahoo.com - February 9 at 7:15 PM
USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue EstimatesUSANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates
finance.yahoo.com - February 9 at 7:15 PM
Usana Health Sciences Earnings PreviewUsana Health Sciences Earnings Preview
finance.yahoo.com - February 8 at 1:52 PM
USNA: Lowering target price to $87.00USNA: Lowering target price to $87.00
finance.yahoo.com - February 5 at 12:09 AM
Country Music Star Influences Global CEOCountry Music Star Influences Global CEO
finance.yahoo.com - February 2 at 8:54 AM
Are Investors Overlooking Returns On Capital At USANA Health Sciences (NYSE:USNA)?Are Investors Overlooking Returns On Capital At USANA Health Sciences (NYSE:USNA)?
finance.yahoo.com - January 15 at 3:10 PM
DateCompanyBrokerageAction
3/1/2021Cronos GroupRaymond JamesSet Price Target
3/1/2021Cronos GroupCanaccord GenuityBoost Price Target
2/22/2021Cronos GroupCIBCDowngrade
2/4/2021Cronos GroupStifel NicolausReiterated Rating
11/16/2020Cronos GroupJefferies Financial GroupLower Price Target
5/11/2020Cronos GroupPi FinancialReiterated Rating
4/19/2020Cronos GroupPiper SandlerDowngrade
4/2/2020Cronos GroupBank of AmericaDowngrade
3/4/2020Cronos GroupMKM PartnersUpgrade
2/25/2021TilrayBenchmarkReiterated Rating
2/18/2021TilrayRoth CapitalBoost Price Target
2/18/2021TilrayAlliance Global PartnersBoost Price Target
2/18/2021TilrayBMO Capital MarketsBoost Price Target
2/16/2021TilrayCantor FitzgeraldBoost Price Target
8/11/2020TilrayNorthland SecuritiesReiterated Rating
8/10/2020TilrayOppenheimerReiterated Rating
2/12/2021Aurora CannabisNeedham & Company LLCDowngrade
2/12/2021Aurora CannabisDesjardinsDowngrade
11/16/2020Aurora CannabisAtb Cap MarketsUpgrade
9/23/2020Aurora CannabisCowenReiterated Rating
9/27/2019Sundial GrowersBarclaysInitiated Coverage
5/12/2020USANA Health SciencesTigress FinancialReiterated Rating
7/24/2019USANA Health SciencesPivotal ResearchReiterated Rating
7/3/2019USANA Health SciencesSidotiDowngrade
(Data available from 4/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.